You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

effector memory T lymphocytes

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent DLBCL, Recurrent Mantle Cell Lymphoma, Refractory DLBCL Trial in Duarte (Autologous

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Leukemia, Myeloid, Acute, MDS Trial in Wurzburg (TCM allogeneic humane central memory T cells, cryopreserved)

Completed
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • TCM allogeneic humane central memory T cells, cryopreserved
  • Wurzburg, Germany
    University Hospital Wuerzburg - Department of Medicine II
Jul 12, 2022

Urinary T Cell Biomarker for Prediction in Lupus Nephritis

Active, not recruiting
  • Lupus Nephritis
  • Flow cytometry analysis of urine samples
  • Berlin, Germany
  • +1 more
Mar 8, 2022

CNS Lymphoma Trial in Duarte (procedure, biological, drug)

Recruiting
  • Central Nervous System Lymphoma
  • Aspiration
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • boost anti-viral immunity after T-cell depleted HSCT
  • Moscow, Russian Federation
    Federal Research Center for pediatric hematology, oncology and i
Oct 1, 2021

Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Aldesleukin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 15, 2021

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Urinary T Lymphocytes Predict Renal Flares in Inactive

Completed
  • Glomerulonephritis Acute
  • Analysis of urine samples with flow cytometry
  • Berlin, Germany
  • +1 more
Mar 8, 2022

DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • +5 more
  • Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Malignant Brain Tumor, Recurrent Malignant Brain Tumor, Refractory Malignant Brain Tumor Trial in Duarte (Cyclophosphamide,

Recruiting
  • Malignant Brain Neoplasm
  • +2 more
  • Duarte, California
    City of Hope Medical Center
May 19, 2022

Tissue-resident Memory T Cells Expression Among Repigmentation

Completed
  • Vitiligo
    • San Luis Potosí, Mexico
      Dermatology Department. Hospital Central "Dr. Ignacio Morones Pr
    Aug 16, 2022

    Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +6 more
    • Anti-Thymocyte Globulin
    • +5 more
    • Stanford, California
      Stanford University, School of Medicine
    Jun 1, 2021

    Recurrent Glioblastoma, Refractory Glioblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory

    Recruiting
    • Recurrent Glioblastoma
    • Refractory Glioblastoma
    • IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Oct 29, 2021

    AML/MDS Trial in Copenhagen (iDLI)

    Recruiting
    • AML/MDS
    • iDLI
    • Copenhagen, Denmark
      Copenhagen University Hospital, Rigshospitalet
    Jan 13, 2023

    Solid Tumor Trial in Tianjin (LM103)

    Recruiting
    • Solid Tumor
    • LM103
    • Tianjin, China
      Tianjin Beichen Hospital
    Jul 4, 2023

    Alterations in CD8aß and CD8aa T Cell Levels in Rheumatoid

    Not yet recruiting
    • Rheumatoid Arthritis
    • flow cytometry
    • (no location specified)
    Apr 12, 2023

    Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Cryoablation
    • Cryoablation combined with PD1 Inhibitor
    • (no location specified)
    Mar 28, 2023

    Tissue-resident Memory T Cells Expression in Melasma

    Completed
    • Melasma
      • San Luis Potosí, Mexico
        Dermatology Department. Hospital Central "Dr. Ignacio Morones Pr
      Jan 15, 2023

      Influenza, Healthy Trial in Stanford (Fluzone®, FluMist®)

      Completed
      • Influenza
      • Healthy
      • Fluzone®
      • FluMist®
      • Stanford, California
        Stanford University
      Feb 11, 2020

      Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

      Not yet recruiting
      • Advanced Sarcoma
      • NKG2D-CAR memory T cell
      • (no location specified)
      Oct 17, 2023

      Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

      Terminated
      Has Results
      • Advanced Pleural Malignant Mesothelioma
      • +10 more
      • Aldesleukin
      • +4 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 16, 2021

      Healthy Trial (763SIP8/MPLA-5 vaccine)

      Not yet recruiting
      • Healthy
      • 763SIP8/MPLA-5 vaccine
      • (no location specified)
      Mar 15, 2023

      Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

      Not yet recruiting
      • Glioblastoma Multiforme of Brain
      • TVI-Brain-1
      • +3 more
      • (no location specified)
      Jan 13, 2023

      Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

      Not yet recruiting
      • Oropharyngeal Cancer
      • +10 more
      • (no location specified)
      Dec 14, 2022

      BeAT1D: Benign Autoimmunity and Type 1 Diabetes

      Recruiting
      • Type 1 Diabetes
      • Biosampling
      • Bobigny, Ile-de-France, France
      • +16 more
      Dec 1, 2022